EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study

Jennifer D Brooks, Ashley Mah, Rebecca A G Christensen, Jasleen Arneja, Andrea Eisen, Anna M Chiarelli

Genetics in Medicine · 2023

DOI: 10.1016/j.gim.2023.100820 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Genetics in Medicine, 2023. Verfasst von Jennifer D Brooks und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dalla Lana School of Public Health, Division of Epidemiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: jennifer.brooks@ut…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, University of Toronto Connaught Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Women with a remaining lifetime risk of breast cancer of ≥25%, estimated using the International Breast Cancer Intervention Study (IBIS) model, were eligible for the High Risk Ontario Breast Screening Program. This study examined the performance of IBIS 10-year risk estimates in the program. METHODS: This retrospective study included 7487 women aged 30 to 69 years referred to the High Risk Ontario Breast Screening Program between July 1, 2011, and December 31, 2016, with follow-up until December 31, 2018. Model calibration and discrimination were assessed. Analyses were conducted overall and stratified by age (< or ≥50 years). Different 10-year risk thresholds were compared with the current eligibility criteria. RESULTS: Overall, IBIS overestimated the risk of breast cancer with an expected vs observed case ratio of 1.17 (95% CI = 1.04-1.35). Overestimation was highest in women aged 50 to 69 years (expected vs observed case ratio = 1.29, 95% CI = 1.03-1.69) and for those in the top quartile of risk. Overall discrimination was fair with a concordance statistic of 0.66 (95% CI = 0.63-0.70). Furthermore, when using different 10-year risk eligibility thresholds, most cases would have been missed in the 30 to 49 age group using the 8% 10-year risk threshold, whereas relatively few women aged 50 to 69 would have been ineligible at any of the thresholds examined. CONCLUSION: We found that IBIS overestimated the risk of breast cancer in this screening cohort but had adequate discrimination. Age-specific risk thresholds should be considered to optimize the program eligibility criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansAdultMiddle AgedRetrospective StudiesRisk FactorsOntarioEarly Detection of CancerRisk Assessment

Stichwörter der Autor:innen

Breast cancerHigh riskIBISRisk predictionScreening

Autor:innen und Institutionen

  • Dalla Lana School of Public Health, Division of Epidemiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: jennifer.brooks@utoronto.ca.
  • Dalla Lana School of Public Health, Division of Epidemiology, University of Toronto, Toronto, Ontario, Canada.
  • Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Dalla Lana School of Public Health, Division of Epidemiology, University of Toronto, Toronto, Ontario, Canada; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.

Förderung

  • Canadian Institutes of Health Research
  • University of Toronto Connaught Fund

Zitieren

APA

Brooks, J. D., Mah, A., Christensen, R. A. G., Arneja, J., Eisen, A., & Chiarelli, A. M. (2023). Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study. Genetics in Medicine. https://doi.org/10.1016/j.gim.2023.100820

Vancouver

Brooks JD, Mah A, Christensen RAG, Arneja J, Eisen A, Chiarelli AM. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study. Genetics in Medicine. 2023. doi:10.1016/j.gim.2023.100820

BibTeX
@article{Brooks2023,
  author = {Brooks, Jennifer D and Mah, Ashley and Christensen, Rebecca A G and Arneja, Jasleen and Eisen, Andrea and Chiarelli, Anna M},
  title = {Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study},
  journal = {Genetics in Medicine},
  year = {2023},
  doi = {10.1016/j.gim.2023.100820}
}
Kostenlos starten →